BioNxt Solutions Inc
CNSX:BNXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
CA |
|
S
|
Sugih Energy Tbk PT
IDX:SUGI
|
ID |
|
Shanghai Electric Wind Power Group Co Ltd
SSE:688660
|
CN |
|
O
|
Obocon Inc
OTC:OBCN
|
US |
|
M
|
Mobile Appliance Inc
KOSDAQ:087260
|
KR |
|
MainStreetChamber Holdings Inc
OTC:MSCH
|
US |
|
L
|
Lipidor AB
STO:LIPI
|
SE |
|
Adomos SA
F:Y2A
|
FR |
BioNxt Solutions Inc
BioNxt Solutions, Inc. engages in the production, extraction and sale of medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets.
BioNxt Solutions, Inc. engages in the production, extraction and sale of medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets.
